Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01229163 · ClinicalTrials.gov registry record · Early Phase 1
Automated Prize-based Contingency Management to Increase Counseling Attendance in Opiate-Replacement-Therapy Patients
A Early Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT01229163 is a Early Phase 1 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 25 participants.
The verdict
NCT01229163, a Early Phase 1 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
Background: \- Treatment outcomes for substance abuse are improved by regular attendance at counseling sessions, and attending at counseling sessions can be futher improved by prize-based incentives. However, a system of prize-based incentives can be difficult to administer without computerization for accurate recordkeeping and rapid calculation of earnings. NIDA researchers have developed the eXtensible Platform for Motivational Incentives (XPMI), a computer program that for reinforcement of weekly counseling attendance. Users are eligible to win prizes through automated draws. The researchers are interested in testing the effectiveness and ease of use of the XPMI software so it can ultimately be run by staff in community treatment programs. Objectives: * To test the XPMI program in a clinic setting, with emphasis on its functionality, usability, and acceptability for counselors. * To test and validate XPMI s accuracy in calculating incentives to reinforce drug abstinence. Eligibility: \- Individuals at least 18 years of age who are participating in clinical trials for treatment of heroin dependence in an outpatient treatment-research program, and have at least 14 weeks remaining in the program. Design: * Participants will meet with their counselors as regularly scheduled. Twelve of the visits will count toward this study, with 2 extra weeks in case of counselor absence or clinic closure. * Participants will receive an incentive in the form of a prize draw for arriving to counseling appointments on time, on the scheduled day. (Participants may reschedule one appointment per week without losing the chance for a prize draw.) For each consecutive appointment attended on time, participants will receive extra prize draws; attending three counseling appointments in a row can earn four bonus prize draws. * To draw for prizes, participants will push a button on a computer. Each prize draw could result in a small prize worth $1 to $2, a large prize worth $20, a jumbo
Interventions
- DEVICE Automated Contingency Management (ACM) software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-10-03 |
| Est. Completion | 2012-04-19 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01229163
The ClinicalTrials.gov registry entry for NCT01229163 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Automated Contingency Management (ACM) software is the first listed.
NCT01229163 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01229163 about?
NCT01229163 is a clinical study titled "Automated Prize-based Contingency Management to Increase Counseling Attendance in Opiate-Replacement-Therapy Patients". Background: \- Treatment outcomes for substance abuse are improved by regular attendance at counseling sessions, and attending at counseling sessions can be futher improved by prize-based incentives. However, a system of prize-based incentives can be difficult to administer without computerization ...
What is the current status of trial NCT01229163?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2010-10-03. Estimated completion is 2012-04-19.
What interventions are being tested in trial NCT01229163?
The interventions under investigation include: Automated Contingency Management (ACM) software (DEVICE).
Who is sponsoring clinical trial NCT01229163?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.